Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alx Oncology Holdings (ALXO) Leases (2021 - 2026)

Alx Oncology Holdings' Leases history spans 3 years, with the latest figure at $4.8 million for Q4 2023.

  • On a quarterly basis, Leases rose 1515.67% to $4.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was $4.8 million, a 1515.67% increase, with the full-year FY2023 number at $4.8 million, up 1515.67% from a year prior.
  • Leases hit $4.8 million in Q4 2023 for Alx Oncology Holdings, down from $5.0 million in the prior quarter.
  • Over the last five years, Leases for ALXO hit a ceiling of $6.1 million in Q2 2022 and a floor of $300000.0 in Q4 2022.
  • Historically, Leases has averaged $3.7 million across 3 years, with a median of $4.9 million in 2023.
  • Biggest five-year swings in Leases: plummeted 83.33% in 2022 and later skyrocketed 1515.67% in 2023.
  • Tracing ALXO's Leases over 3 years: stood at $1.8 million in 2021, then plummeted by 83.33% to $300000.0 in 2022, then skyrocketed by 1515.67% to $4.8 million in 2023.
  • Business Quant data shows Leases for ALXO at $4.8 million in Q4 2023, $5.0 million in Q3 2023, and $5.2 million in Q2 2023.